IFP Advisors’s Aegerion Pharmaceuticals AEGR Stock Holding History
Bought
Maintained
Sold
IFP Advisors's AEGR Position: Q4 2016 in Review
IFP Advisors sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 100 shares.
IFP Advisors first reported a position in AEGR in Q2 2016 and held it in 2 quarters. The position peaked at $0 in Q3 2016. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.
- IFP Advisors reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
- IFP Advisors sold 100 Aegerion Pharmaceuticals shares in Q4 2016.
- IFP Advisors first reported a position in Aegerion Pharmaceuticals in Q2 2016 and held it in 2 quarters.
- IFP Advisors's Aegerion Pharmaceuticals position peaked at $0 in Q3 2016.
- 0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.
Based on IFP Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.